CD44 and cancer: RNAPII occupancy also mirrored that of NELF-E binding (Fig. 4d), as exemplified by cancer stem cell marker CD44 and mesenchymal gene FN1, both of which are upregulated upon Dox induction in control cells but curtailed in NELF-E KD cells (Fig. 4e).